Online healthcare company Teladoc Health’s shares fell Thursday as several analysts lowered their share-price targets – following lower-than-expected quarterly earnings.
Teladoc reported a loss of -$1.31 a share, steeper than the -40 cents loss expected by analysts. It is also wider than the year-ago quarter’s -40 cents per share.
Evercore ISI’s Elizabeth Anderson slashed her price target to $185 from $195 and kept her in-line rating. While she viewed the membership forecast and lower guidance for EBITDA in the second half of 2021, on rising expenses as negatives, she saw tailwinds in the increased revenue outlook, including the combined sales pipeline and TDOC’s specialty and mental health traction.
Citi analyst Daniel Grosslight lowered his price target on Teladoc shares to $260 from $275, but maintained his buy rating. “By most metrics, TDOC’s quarter was solid,” he said, but added that Teladoc faces “greater competitive intensity.”
Cowen analyst Charles Rhyee cut his price target to $240 from $268, while keeping his outperform rating. According to Rhyee, earnings were strong, but investors expected more and were disappointed visit gains “didn’t flow through to revenue.”
TDOC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 16, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on April 01, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on TDOC as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TDOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for TDOC entered a downward trend on April 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
TDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.066) is normal, around the industry mean (29.847). P/E Ratio (0.000) is within average values for comparable stocks, (155.253). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.725). Dividend Yield (0.000) settles around the average of (0.081) among similar stocks. P/S Ratio (0.939) is also within normal values, averaging (55.178).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TDOC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TDOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a telephone and online video consultation service
Industry PackagedSoftware